HI

Hashmukhbhai Ishwarlal Patel

Active Director Whole-Time Director DIN 00104834
DIN 00104834 First appointment Jan 1995 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Jan 1995
Shareholding value •••• Premium profile

About Hashmukhbhai Ishwarlal Patel

Data last updated:

Hashmukhbhai Ishwarlal Patel has 31 years in corporate governance. Holds Whole-Time Director and Director roles. Currently with 3 companies, including Lincoln Pharmaceuticals Ltd and Zullinc Healthcare Limited. Formerly with 3 companies, such as Brillare Science Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹648 Cr; the largest is Lincoln Pharmaceuticals Ltd at ₹646 Cr (FY 2025).

DIN 00104834
Primary Designation Whole-Time Director
First Appointment 20 Jan 1995
Oldest Company Age 31 yrs
Largest company Lincoln Pharmaceuticals Ltd · ₹646 Cr (FY 2025)
Combined revenue ₹648 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lincoln Pharmaceuticals Ltd L24230GJ1995PLC024288
Whole-Time Director20 Jan 19951995₹646 Cr (FY 2025)Active
Director04 Feb 20162016₹2.78 Cr (FY 2025)Active
Designated Partner01 Feb 20162016–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Brillare Science Limited U24100GJ2015PLC084144
Director10 Aug 20152015₹79.83 Cr (FY 2026)Active
Zullinc Healthcare Limited U24230GJ2008PLC055251
Director16 Oct 20082008₹42.8 Lakh (FY 2015)Converted To Llp
Sls Metal (India) Private Limited U28910GJ2008PTC052857
Director01 Sep 20122008–Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lincoln Pharmaceuticals Ltd
Zullinc Healthcare Limited
Cosmetics Concept Research Private Limited
Sls Metal (India) Private Limited
Premium access

Shareholding and investment profile for Hashmukhbhai Ishwarlal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hashmukhbhai Ishwarlal Patel

Hashmukhbhai Ishwarlal Patel has 31 years in corporate governance. Holds Whole-Time Director and Director roles. Currently with 3 companies, including Lincoln Pharmaceuticals Ltd and Zullinc Healthcare Limited. Formerly with 3 companies, such as Brillare Science Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 2 current companies with reported revenue have a combined latest revenue of ₹648 Cr; the largest is Lincoln Pharmaceuticals Ltd at ₹646 Cr (FY 2025).

Hashmukhbhai Ishwarlal Patel is associated with 3 companies as Whole-Time Director and Director, including Lincoln Pharmaceuticals Ltd (₹646 Cr), Cosmetics Concept Research Private Limited (₹2.78 Cr), Zullinc Healthcare Llp.

Hashmukhbhai Ishwarlal Patel has expertise in General Business, Healthcare.

Hashmukhbhai Ishwarlal Patel has 31 years in corporate governance.

By reported revenue, the largest current company of Hashmukhbhai Ishwarlal Patel is Lincoln Pharmaceuticals Ltd, with revenue of ₹646 Cr (FY 2025).

The 2 current companies of Hashmukhbhai Ishwarlal Patel that report revenue have a combined latest revenue of ₹648 Cr.

Hashmukhbhai Ishwarlal Patel currently holds positions at 3 companies: Lincoln Pharmaceuticals Ltd (₹646 Cr), Cosmetics Concept Research Private Limited (₹2.78 Cr), Zullinc Healthcare Llp.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available